Ms Direct (Morphine Sulfate)

• Morphine is an opioid analgesic used to manage pain through central nervous system pathways.
• Moderate to severe acute pain: provides rapid analgesia after surgery or trauma
• Cancer‑related pain: helps control persistent pain in oncology patients
• Palliative‑care pain: alleviates distressing pain in end‑of‑life settings

• Morphine exerts its analgesic effect by binding as a full agonist to mu‑opioid receptors located in the brain, spinal cord and peripheral nervous system. Activation of these G‑protein‑coupled receptors inhibits the release of excitatory neurotransmitters, reduces neuronal excitability, and modulates pain signal transmission, resulting in decreased perception of pain. The effect is dose‑dependent and can be reversed by opioid antagonists such as naloxone.

Morphine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: feeling of sickness often accompanied by vomiting
• Constipation: reduced bowel movements, may require laxatives
• Drowsiness: increased sleepiness or fatigue
• Dizziness: light‑headed sensation, especially when standing quickly

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, potentially life‑threatening
• Severe hypotension: marked drop in blood pressure leading to faintness
• Dependence or addiction: risk of psychological or physical reliance with prolonged use

• When prescribing morphine, clinicians should consider several safety measures to minimize risk.
• Assess pain severity: confirm that opioid therapy is appropriate
• Screen for respiratory disorders: monitor breathing function regularly
• Evaluate renal and hepatic function: adjust dose if impairment is present
• Avoid concomitant CNS depressants: increased risk of sedation and respiratory depression
• Educate patient on signs of overdose: advise immediate medical attention if symptoms appear
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Morphine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Benzodiazepines: additive central nervous system depression increasing sedation and respiratory risk
• Alcohol: synergistic depressant effect that may cause profound respiratory depression
• MAO inhibitors: potential for severe hypertension or serotonin syndrome when combined

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may raise morphine plasma concentrations
• CYP3A4 inducers (e.g., rifampin): may reduce analgesic effectiveness
• Anticholinergics: can exacerbate constipation, a common opioid side effect